Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citigroup Maintains Buy on Macrogenics, Raises Price Target to $16

Citigroup analyst Yigal Nochomovitz maintains Macrogenics (NASDAQ:MGNX) with a Buy and raises the price target from $13 to $16.
byBenzinga Newsdesk
August 29, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Citigroup analyst Yigal Nochomovitz maintains Macrogenics (NASDAQ:MGNX) with a Buy and raises the price target from $13 to $16.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Mixed Bag In Paradise: Bank Of Hawaii Q4 Beats On Profit, Despite Revenue Miss, Net Interest Income Takes A Dive

By Lekha Gupta
January 22, 10:18 AM
Bank of Hawaii (BOH) reports Q4 FY23 results, with revenues at $158.07 million, slightly below estimates. The bank, however, exceeds expectations with an Adjusted EPS of $1.01, despite a 4.3% Q/Q dip in net interest income. Total deposits reach $21.1 billion, reflecting consistent growth. Noninterest income, at $42.3 million, experiences a modest Q/Q decline but maintains a positive Y/Y trajectory.

BOH